Clozapine and gastrointestinal hypomotility
CNS Drugs | Dec 15, 2017
Cohen D - This study was performed to examine the association between clozapine use and risk of gastrointestinal hypomotility (GIH) in patients with therapy-resistant schizophrenia. For the whole duration of clozapine treatment, alertness for and/or treatment of GIH was required, as the occurrence of severe cases of GIH was not restricted to a certain treatment duration.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries